Back to Directory Jonathan Lucas Email Phone Institution FHI 360 Request an Update Affiliated Studies IMPAACT 2008: Phase I/II Multisite, Randomized, Controlled Study of Monoclonal Antibody VRC01 with Combination Antiretroviral Therapy to Promote Clearance of HIV-1-Infected Cells in Infants DAIDS Number 20735 Research Area Cure Study Status Closed to Follow Up Locality US & Non-US IMPAACT 2023: A Phase I Study of the Safety and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1 DAIDS Number 38637 Research Area Treatment Study Status In Development Locality US & Non-US IMPAACT 2020: SMaRT Kids DAIDS Number 38505 Research Area Tuberculosis Study Status In Development Locality Non-US
IMPAACT 2008: Phase I/II Multisite, Randomized, Controlled Study of Monoclonal Antibody VRC01 with Combination Antiretroviral Therapy to Promote Clearance of HIV-1-Infected Cells in Infants DAIDS Number 20735 Research Area Cure Study Status Closed to Follow Up Locality US & Non-US
IMPAACT 2023: A Phase I Study of the Safety and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1 DAIDS Number 38637 Research Area Treatment Study Status In Development Locality US & Non-US
IMPAACT 2020: SMaRT Kids DAIDS Number 38505 Research Area Tuberculosis Study Status In Development Locality Non-US
